ENDURANT CAPITAL MANAGEMENT LP – Boston Scientific Corporation Transaction History
ENDURANT CAPITAL MANAGEMENT LP portfolio value:
$0
portfolio value
ENDURANT CAPITAL MANAGEMENT LP quarter portfolio value change:
+3.92%
quarter
Boston Scientific Corporation 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -418.16K shares | -15.58M | $38.73 | 0 |
| Q2 2022 | share | Increase | 0.00% | 418.16K shares | 15.58M | $37.27 | 418.16K |
| Q2 2021 | share | Decrease | -100.00% | -158.70K shares | -6.13M | $42.76 | 0 |
| Q1 2021 | share | Increase | 0.00% | 158.70K shares | 6.13M | $38.65 | 158.70K |
| Q3 2020 | share | Decrease | -100.00% | -106.33K shares | -3.73M | $38.21 | 0 |
| Q2 2020 | share | Increase | 0.00% | 106.33K shares | 3.73M | $35.11 | 106.33K |
| Q1 2019 | share | Decrease | -100.00% | -30.56K shares | -1.08M | $38.38 | 0 |
| Q4 2018 | share | Decrease | -56.60% | -39.84K shares | -1.63M | $35.34 | 30.56K |
| Q3 2018 | share | Decrease | -3.34% | -2.43K shares | 329K | $38.5 | 70.40K |
| Q2 2018 | share | Decrease | -81.21% | -314.85K shares | -8.21M | $32.7 | 72.84K |
| Q1 2018 | share | Increase | +13.16% | 45.1K shares | 2.09M | $27.32 | 387.69K |
| Q4 2017 | share | Increase | +62.76% | 132.1K shares | 2.35M | $24.79 | 342.59K |
| Q3 2017 | share | Increase | +64.84% | 82.8K shares | 2.6M | $29.17 | 210.49K |
| Q2 2017 | share | Decrease | -43.55% | -98.5K shares | -2.08M | $27.72 | 127.69K |
| Q1 2017 | share | Decrease | -31.91% | -106K shares | -1.55M | $24.87 | 226.19K |
| Q4 2016 | share | Increase | +28.61% | 73.9K shares | 1.03M | $21.63 | 332.19K |
| Q3 2016 | share | Decrease | -29.62% | -108.7K shares | -2.43M | $23.8 | 258.29K |
| Q2 2016 | share | Decrease | -30.32% | -159.7K shares | -1.33M | $23.37 | 366.99K |
| Q1 2016 | share | Increase | +90.76% | 250.6K shares | 4.81M | $18.81 | 526.69K |